Breaking News, Promotions & Moves

Intercept Appoints Juan Carlos Lopez-Talavera SVP Medical Affairs

Most recently served as head of hepatology R&D and vice president of medical affairs at Abbvie

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Intercept Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic underserved liver diseases, such as primary biliary cirrhosis (PBC) and nonalcoholic steatohepatitis (NASH), has named Juan Carlos Lopez-Talavera as senior vice president of medical affairs. “Juan Carlos brings more than 20 years of industry and academic experience to Intercept and is a globally recognized hepatologist,” said David...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters